Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1

Interventions

pembrolizumab 3venetoclax 2selpercatinib 2obinutuzumab 2ibrutinib 2decitabine and cedazuridine drug combination 2cedazuridine 2Rituximab 2Nivolumab 2Midazolam 2Ipilimumab 2Decitabine 2Crizotinib 2zanubrutinib 1trametinib 1toripalimab 1tocilizumab 1tazemetostat 1tagraxofusp 1sotorasib 1sacituzumab govitecan 1romiplostim 1revumenib 1repotrectinib 1prednisolone phosphate 1prednisolone acetate 1pralsetinib 1polatuzumab vedotin 1pirtobrutinib 1olutasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Has announcements × AZD 6244 × Clear all
NCT01362803 2026-06-01

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡